About
Fusion Protein
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
727
By Phase
PHASE2: 2PHASE1: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05618782Lead Sponsor
Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee
PHASE2Completed
518 participants
Started: Oct 19, 2022 · Completed: May 20, 2024
NCT05008393Collaborator
Efficacy of PJS-539 for Adult Patients With COVID-19.
PHASE2Completed
153 participants
Started: Sep 25, 2021 · Completed: Mar 4, 2022
NCT03227796Lead Sponsor
Safety, Tolerability & Pharmacokinetics of LEVI-04 in Healthy Volunteers and Patients With Osteoarthritis Knee Pain
PHASE1Completed
56 participants
Started: Jul 28, 2017 · Completed: Mar 31, 2021
Locations (1)
Headquarters
Kent, UK
Map
Loading map...